ArticleFrontiers in immunology2020

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation.

Linda Voss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.